Why do we display adverts? The advertisements supplied by our carefully selected sponsors enable us to host and support the company data we share with our free members.
Simply enter your email address below and we will send you an email when the company files any documents or there is a change to their credit report.
We require your email address in order to send you alerts by email. You can unsubscribe at any time.
You will receive email updates when this company's information changes.
You can choose which alerts you receive and can unsubscribe at any time.
5 Credit Reports
*Billed Annually, Cancel any time.
Your plan will start immediately and the time remaining on your existing plan will be refundedYes, upgrade to Lite
Includes Risk Score, Credit Limit, CCJs, Mortgages & Charges, Director & Secretary Timeline, Shareholders, Ownership & Group Stucture. Plus UNLIMITED updates and FREE documents!
Private limited with Share Capital
Active - Accounts Filed
12 April 2013
72110 Research and experimental development on biotechnology -
Available to 31 Mar 2018. Next accounts due by 31 Dec 2019
For a full in-depth analysis on each of these directors, click any of the links below
|Name||Role||Date Of Birth||Appointed||Resigned|
|MR ROBERT LEARMONTH SNEDDEN||Company Secretary||-|
|MR CHRISTOPHER JAMES THOMPSON||Director||-|
|PROFESSOR JULIAN BRAJENDRA CHAUDHURI||Director||-|
|MR FRANCIS JOSEPH DAVID BEALIN-KELLY||Director||-|
|DR MARIANNE JANE ELLIS||Director||-|
|MR WILLIAM REGINALD ALLBROOK||Director||-|
|MR JOHN RICHARD ALLBROOK||Director||-|
|MR MARK COLE||Director||-|
|MR NICHOLAS DUGGAN||Director||-|
|MR TREVOR DALE||Director||-|
|MR JONATHAN MARK TREHERNE||Director||-|
|Mr Nicholas Duggan||Company Secretary|
Sign Up Today to unlock this company's full accounts
|Total Current Liabilities||£0.00||£3,675.00||£19,113.00||£8,921.00||£104,817.00|
|Total Current Assets||£0.00||£1,143.00||£54,964.00||£340,949.00||£620,305.00|